Navigation Links
Bioforce Announces Echinaforce® Named One of Three Top Supplements for Cold and Flu
Date:12/6/2013

Ghent, New York (PRWEB) December 06, 2013

On November 27, 2013 Dr. Oz named Echinaforce® from A. Vogel as one of the top three supplements for cold and flu. His website states: “the A. Vogel product has not yet been tested by ConsumerLab.com, but a clinical study published after we completed our tests found it to reduce the number of cold episodes and their duration by 26% if taken throughout the cold season.”

Echinaforce®, produced by A. Vogel is made according to Swiss Pharmaceutical Good Manufacturing Practices in Roggwil, Switzerland. As part of these GMP’s each batch is tested to ensure that what is on the label is in the bottle. And even though the Echinacea is certified organically grown, the plants and water used in each batch are also tested to ensure there is no contamination with heavy metal residues, pesticides and microbial and fungal contamination.

The efficacy of Echinaforce in supporting a healthy immune system has been shown in 14 published studies, including the world’s largest double blind, randomized, published clinical study on Echinacea to date. Each study has consistently shown efficacy in various parameters of immune health. Bioforce AG, Rogwill, Switzerland is known for its “gold standard” research on herbs. Bioforce received the American Botanical Council’s Varro E. Tyler Commercial Investment in Phytomedicinal Research Award in 2011. It’s meta-analysis on Echinacea was chosen as one of the top 25 research papers for the prestigious Annual Bibliography of Significant Advances in Dietary Supplement Research, published by The National Institutes of Health, (NIH) Office of Dietary Supplements.

Through the years research results on Echinacea have been mixed, while research on Echinaforce has been consistently positive. Commercial preparations of Echinacea Purpurea vary greatly in the manufacturing procedures and consequently in their potency. The latest Echinaforce® study shows that the Vogel combination of fresh 5% Echinacea root and 95% herb, extracted in ethanol provided the optimum modulating effect on the immune system.

Pierce Sioussat, President of Bioforce USA stated “Alfred Vogel, the Swiss Naturopath who founded Bioforce, saw that Echinacea had a wide spectrum of actions, with gentle, yet profound effects on the body. Bioforce has focused its research on understanding the power of this plant to gain the greatest health benefits from it. This latest study is another important step in that direction. It is very gratifying to now have clinical evidence that the unique combination of fresh herb and root that Alfred Vogel determined empirically to be the best, is now proven in multiple published clinical studies.”

About Bioforce USA
Bioforce USA has created long-term strategic alliances with European manufacturers of product lines that have years of clinical research support for safety and efficacy, plus years of repeat consumer use. Bioforce USA has brought these lines, which include A. Vogel, Sanhelios, Herbatint, Annemarie Börlind, Bionorica and SECURE exclusively to the United States for distribution through natural products and health food stores.

For more information call Eileen Sheets at 800-641-7555 x100.

Read the full story at http://www.prweb.com/releases/2013/12/prweb11387640.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Bioforce USA Announces Herbatint Herbal Hair Color Selected For Tips and Trends Again
2. Bioforce AG Announces Doctors Comments Showing Efficacy of Echinaforce for Immune Support Now On You Tube
3. AFAR announces the 2012 Hartford Centers of Excellence in Geriatric Medicine awards
4. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder
5. University of Houston Graduate College of Social Work announces partnership with MD Anderson
6. The Ludwig Institute for Cancer Research announces launch of iTeos Therapeutics SA
7. AGA announces prestigious awards recognition recipients
8. TheBestHeartRateMonitorReviews.com Announces The Top 3 Heart Rate Monitors
9. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
10. Zane Benefits Announces Wellness HRAs: A New Way to Reward Healthy Employees
11. San Francisco’s Advanced Male Medical Center Announces Discount, Discusses Erectile Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ORLEANS, La. (PRWEB) , ... July 21, 2017 ... ... to allow 4th-year medical students improve their chances of acceptance to a residency ... for those who have earned degrees outside the U.S. , According to data ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended hospital ... adjustable beds used in such facilities are specially designed to accommodate patients with a ... , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM REST, ...
(Date:7/20/2017)... MD (PRWEB) , ... July 20, 2017 , ... ... company dedicated to the development of non-invasive devices and systems for monitoring cardiopulmonary ... million. , Proceeds will be used to complete regulatory submissions and fund final ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... July 11, 2017  Bayer has awarded grants totaling more ... part of its prestigious Bayer Hemophilia Awards Program (BHAP). Four ... Philadelphia and Uniformed Services University of the ... the winners. Grant recipients were announced last night during a ... 2017 Congress, Berlin, Germany . ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston Hotel, ... unparalleled access to global decision makers and innovative biotech ... life science leaders during two impactful days. BioPharm America ... delegates with additional networking opportunities with 4,500+ life science ...
Breaking Medicine Technology: